Xenetic Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $614 | $726 | $510 | $671 |
Gross Profit | 614 | 726 | 510 | 671 |
EBITDA | -499 | -1,337 | -1,268 | -1,255 |
EBIT | -1,356 | -1,257 | -1,299 | |
Net Income | -436 | -1,273 | -1,195 | -1,171 |
Net Change In Cash | 614 | 726 | 510 | 671 |
Free Cash Flow | -459 | -525 | -1,159 | -793 |
Cash | 6,839 | 7,298 | 7,823 | 8,983 |
Basic Shares | 1,541 | 1,540 | 1,540 | 1,537 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,539 | $1,706 | $1,160 | $436 |
Gross Profit | 2,539 | 1,679 | 1,125 | 436 |
EBITDA | -4,515 | -6,717 | -5,711 | -4,693 |
EBIT | -4,487 | -6,744 | -5,746 | -4,722 |
Net Income | -4,134 | -6,386 | -5,544 | -10,893 |
Net Change In Cash | 2,539 | 1,706 | 1,160 | 436 |
Cost of Revenue | 1,159 | |||
Free Cash Flow | -4,114 | -5,146 | -4,738 | -4,267 |
Cash | 8,983 | 13,097 | 18,244 | 11,527 |
Basic Shares | 1,528 | 1,422 | 1,027 | 639 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-06-30 | -$0.83 |
2024-03-31 | -$0.78 |
2023-12-31 | -$0.77 |
